| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/27/2007 | US7196058 Method of treatment of conditions by administration of streptolysin O |
| 03/27/2007 | US7196056 A mixture comprising progenitor cells, are stimulated by exposure to a morphogen, tissue-specific cell differentiation and proliferation; tissue-targeted therapy, promoting liver tissue growth |
| 03/27/2007 | US7196055 Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor |
| 03/27/2007 | US7196054 Methods for treating wound tissue and forming a supplemented fibrin matrix |
| 03/27/2007 | US7195916 Method for expression of small antiviral RNA molecules within a cell |
| 03/27/2007 | US7195911 Mammalian cells that have increased proliferative capacity |
| 03/27/2007 | US7195910 Central nervous system disorders; antidiabetic agents |
| 03/27/2007 | US7195903 Comprises metallloenzyme which is fibrinolytically active (fibrolase), for use in treating blood clots in situ |
| 03/27/2007 | US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders |
| 03/27/2007 | US7195896 Complementary adenoviral vector systems and cell lines |
| 03/27/2007 | US7195894 MKK7 activation inhibitor |
| 03/27/2007 | US7195890 Methods and compositions for modulating proteins modified in preconditioning against ischemia/hypoxia |
| 03/27/2007 | US7195886 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents |
| 03/27/2007 | US7195885 Hepatitis C virus assays |
| 03/27/2007 | US7195874 Using conjugate agents comprise of photoreactive moiety to identify preferential micro and/or macromolecules in heterologous mixtures |
| 03/27/2007 | US7195871 Cleaving with nucleases; forensic analysis and paternity testing |
| 03/27/2007 | US7195774 Surgically implantable and sealable drug delivery device that upon contact of its contents via an interface window or port with an organ or tissue exposes a therapeutic agent to organ or tissue surface, allowing a controlled, selective diffusion |
| 03/27/2007 | US7195767 Method to detect IgE |
| 03/27/2007 | US7195766 Product and process for liquefaction of mucus or sputum |
| 03/27/2007 | US7195765 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 03/27/2007 | US7195762 Density enhanced protein tyrosine phosphatases |
| 03/27/2007 | US7195759 Therapeutic uses of glandular kallikrein |
| 03/27/2007 | CA2375787C Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abc1 |
| 03/27/2007 | CA2303810C Antistress agents and functional foods |
| 03/27/2007 | CA2200582C Dna encoding human papillomavirus type 6a |
| 03/27/2007 | CA2141555C Morphogenic protein soluble complex and composition thereof |
| 03/27/2007 | CA2134966C Antibodies with specificity for multiple adhesion molecules |
| 03/27/2007 | CA2084552C Novel synthetic isohirudins with improved stability |
| 03/27/2007 | CA2019580C Novel methods of treatment using ranolazine and related piperazine derivatives |
| 03/26/2007 | CA2560798A1 Administering pharmaceutical compositions to the mammalian central nervous system |
| 03/22/2007 | WO2007033233A2 Stimulating g protein-coupled receptors |
| 03/22/2007 | WO2007033211A2 Regulation of brain natriuretic peptide and catecholamines for the treatment of cardiovascular diseases |
| 03/22/2007 | WO2007033099A2 Prodrugs of phentermine |
| 03/22/2007 | WO2007033096A2 Methods and compositions for diagnosis and treatment of disorders involving macrophages |
| 03/22/2007 | WO2007032997A1 Ophthalmic formulation containing loteprednol etabonate for treatment of dry eye |
| 03/22/2007 | WO2007032887A2 Thio-containing inhibitors of aminopeptidase p, compositions thereof and method of use |
| 03/22/2007 | WO2007032396A1 Therapeutic agent for spinal cord injury |
| 03/22/2007 | WO2007032255A1 T-cell receptor and nucleic acid encoding the receptor |
| 03/22/2007 | WO2007032029A1 Agonist peptides of basic fibroblast growth factor (bfgf) and the method of reduction of wrinkle on skin, darkening of hair and acceleration of wound healing |
| 03/22/2007 | WO2007032018A1 pH SENSITIVE NANOPARTICLE FORMULATION FOR ORAL DELIVERY OF PROTEINS/PEPTIDES |
| 03/22/2007 | WO2007032013A2 Compounds for improving nutritional status, cognition and survival |
| 03/22/2007 | WO2007031853A2 Therapeutic combination of hamlet and a hdac inhibitor to treat cancer |
| 03/22/2007 | WO2007031742A2 Products and methods relating to the use of the endoribonuclease kid/pemk |
| 03/22/2007 | WO2007031727A2 System for delivering neuronal calcium sensor - 1 (ncs - 1) |
| 03/22/2007 | WO2007031574A2 Therapeutic use of outer shigella protein f (os pf) |
| 03/22/2007 | WO2007031343A1 2-(AMINOMETHYL)-5-CHLOROBENZYLAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE CLOTTING FACTOR Xa |
| 03/22/2007 | WO2007031329A2 Use of a collagen of xenogeneic origin |
| 03/22/2007 | WO2007031100A1 Active immunotherapy of life-threatening systemic inflammation |
| 03/22/2007 | WO2007030937A2 Screening proteinase modulators using a chimeric protein and ski-i proprotein convertase substrates and inhibitors |
| 03/22/2007 | WO2007030930A1 Methods and compositions for modulating tumor cell activity |
| 03/22/2007 | WO2007006548A3 Antibacterial amide macrocycles vii |
| 03/22/2007 | WO2006126087A3 Angiotensin i-converting enzyme (ace) inhibitors |
| 03/22/2007 | WO2006123969A3 Agent exhibiting bactericidal action with respect to vegetative and spore cells bacillus anthrasis, anthrax preventing and treating method |
| 03/22/2007 | WO2006113978A3 Insulins combinations |
| 03/22/2007 | WO2006110887A3 Use of glp-1, exendin and agonists thereof to delay or prevent cardiac remodeling |
| 03/22/2007 | WO2006105345A9 Compositions and methods for the control, prevention, and treatment of obesity and eating disorders |
| 03/22/2007 | WO2006103356A3 Use of compounds inducing synthesis of sirt proteins in or for preparing a cosmetic or pharmaceutical composition |
| 03/22/2007 | WO2006103037A3 COMPOSITION CONTAINING β-DEFENSIN 2 |
| 03/22/2007 | WO2006096079A3 Pharmaceutical composition comprising a biosynthetic analog of human insulin, and its use in the treatment of diabetes mellitus. |
| 03/22/2007 | WO2006078421A3 Methods of increasing cerebral blood flow |
| 03/22/2007 | WO2006076471A3 Bnp conjugates and methods of use |
| 03/22/2007 | WO2006076414A3 Identification of phospholipase a2 as target in cancer treatment, with special emphasis on colorectal cancer and its mechanism of action |
| 03/22/2007 | WO2006066214A3 Use of flagellin in the immunotherapy of yersinia pestis |
| 03/22/2007 | WO2006036179A3 Frizzled proteins and detection and treatment of cancer |
| 03/22/2007 | WO2006020581A3 Prevention and treatment of synucleinopathic and amyloidogenic disease |
| 03/22/2007 | WO2006009699A3 Targeting damaged lung tissue |
| 03/22/2007 | WO2005120550A3 A method for altering the cd4/cd8 ratio and the mononuclear cellular infiltrate into a tumor |
| 03/22/2007 | US20070067861 Cloning pigs using donor nuclei from differentiated cells |
| 03/22/2007 | US20070067857 Therapeutic agent for NGF |
| 03/22/2007 | US20070067856 Therapeutic agent for NGF |
| 03/22/2007 | US20070066935 Needleless syringe having medical agent accomodated therein |
| 03/22/2007 | US20070066813 Immunoglobulin fusion comprising blood glycoprotein with reduced glycosylation for use in prevention and treatment of septic shock, cachexia, viral and parasitic infection, autoimmune, arthritic and/or graft rejection |
| 03/22/2007 | US20070066812 Fibroblast growth factor homologous factor-2 and methods of use |
| 03/22/2007 | US20070066811 Adipocyte complement related protein zacrp3x2 |
| 03/22/2007 | US20070066810 Homogeneous preparations of il-28 and il-29 |
| 03/22/2007 | US20070066808 Cytokine zalpha11 ligand fusion proteins |
| 03/22/2007 | US20070066807 Cytokine zalpha11 ligand fusion proteins |
| 03/22/2007 | US20070066803 Method to control tumor progression and invasiveness |
| 03/22/2007 | US20070066800 Apo2l(trail) receptor binding peptides and uses thereof |
| 03/22/2007 | US20070066798 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 03/22/2007 | US20070066664 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses, materials for their synthesis |
| 03/22/2007 | US20070066575 Methods and compositions for mitigating pain |
| 03/22/2007 | US20070066555 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/22/2007 | US20070066554 Immunostimulatory nucleic acids |
| 03/22/2007 | US20070066549 Modified antisense oligonucleotide; antitumor and anticancer agents |
| 03/22/2007 | US20070066548 Globin variant gene methods and compositions |
| 03/22/2007 | US20070066547 Ligands |
| 03/22/2007 | US20070066541 Compositions and methods for the intraocular transport of therapeutic agents |
| 03/22/2007 | US20070066540 Growth Hormone Secretagogue Receptor Type 1A Agonists |
| 03/22/2007 | US20070066539 Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof |
| 03/22/2007 | US20070066538 Treatment of wounds |
| 03/22/2007 | US20070066537 Compounds and compositions for prevention of overdose of oxycodone |
| 03/22/2007 | US20070066536 Methods for treating hormone associated conditions using a combination of LHRH antagonists and specific estrogen receptor modulators |
| 03/22/2007 | US20070066535 Novel amino acid sequences are within the carboxy termini of fibrinogen; useful for cell culture and cell separation |
| 03/22/2007 | US20070066534 Comprising a polypeptide conjugated to one or more lipid moieties; synthetic; highly soluble; contraceptive agent ; vaccine |
| 03/22/2007 | US20070066533 Cell adhesion inhibitors |
| 03/22/2007 | US20070066532 Compositions and methods for treatment of muscle pain and muscle wasting |
| 03/22/2007 | US20070066531 Enhanced membrane binding affinityl blood coagulation |
| 03/22/2007 | US20070066530 Methods for modulating gastric secretion using prokineticin receptor antagonists |
| 03/22/2007 | US20070066528 Methods and compositions for treating polycystic ovary syndrome |